49 results on '"Solomon, Scott"'
Search Results
2. HLA evolutionary divergence (HED) informs the effect of HLA-B mismatch on outcomes after haploidentical transplantation
3. A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials
4. Heart failure with preserved ejection fraction
5. Gut microbiota, blood metabolites, and left ventricular diastolic dysfunction in US Hispanics/Latinos
6. Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation
7. CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
8. Firibastat Versus Ramipril After Acute Mechanical Reperfusion of Anterior Myocardial Infarction: A Phase 2 Study
9. Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD)
10. Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
11. Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
12. Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
13. Weight changes in heart failure with preserved ejection fraction: findings from TOPCAT
14. Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study
15. Feasibility of randomizing Danish citizens aged 65–79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial
16. Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials
17. A formal validation of a deep learning-based automated workflow for the interpretation of the echocardiogram
18. Inferences for current chronic graft-versus-host-disease free and relapse free survival
19. Computational Modeling Studies of the Roles of Left Ventricular Geometry, Afterload, and Muscle Contractility on Myocardial Strains in Heart Failure with Preserved Ejection Fraction
20. Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE
21. Accuracy of ICD-10 Diagnostic Codes to Identify COVID-19 Among Hospitalized Patients
22. Developing and validating models to predict sudden death and pump failure death in patients with heart failure and preserved ejection fraction
23. The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation
24. Real-world outcomes of unselected elderly acute myeloid leukemia patients referred to a leukemia/hematopoietic cell transplant program
25. Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomes
26. Safety and efficacy of rituximab-based first line treatment of chronic GVHD
27. Cardiovascular implications of COVID-19 versus influenza infection: a review
28. Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial
29. Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older
30. Long term survival among patients who are disease free at 1-year post allogeneic hematopoietic cell transplantation: a single center analysis of 389 consecutive patients
31. Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial
32. Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes
33. Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative
34. Navigating the Future of Cardiovascular Drug Development—Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference
35. The Myth of Making Inferences for an Overall Treatment Efficacy with Data from Multiple Comparative Studies Via Meta-Analysis
36. Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT
37. Influence of Physical Activity on Hypertension and Cardiac Structure and Function
38. Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT
39. Site selection for heart failure clinical trials in the USA
40. Effect of Aliskiren in Patients with Heart Failure According to Background Dose of ACE Inhibitor: A Retrospective Analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) Trial
41. Therapeutic approaches to diastolic dysfunction
42. Treatment of asymptomatic left ventricular dysfunction
43. Early use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers: Evidence from clinical trials
44. Optimizing care of heart failure after acute MI with an aldosterone receptor antagonist
45. Left ventricular diastolic function following myocardial infarction
46. ACE Inhibitors and Angiotensin Receptor Antagonists and the Incidence of New-Onset Diabetes Mellitus: An Emerging Theme
47. Effect of Radiofrequency Catheter Ablation of Ventricular Tachycardia on Left Ventricular Function in Patients with Prior Myocardial Infarction
48. Survival in Acute Myocardial Infarction Induced by Coronary Ligation: Prognostic Relevanceof Certain Hemostatic Factors During the Occlusion Phase
49. The impact of family and peer differentiation levels on adolescent psychosocial development and problematic behaviors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.